LEADER 01388nas  2200457-a 450 
001 9910144990003321
005 20210621172509.0
011   $a1942-0870
035   $a(OCoLC)225933748
035   $a(CKB)1000000000392510
035   $a(CONSER)--2008215260
035   $a(DE-599)ZDB2537838-7
035   $a(EXLCZ)991000000000392510
100   $a20080422a20099999  s--            a
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMAbs
210   $aAustin, TX $cLandes Bioscience$d2009-
300   $aRefereed/Peer-reviewed
311   $a1942-0862 
606   $aMonoclonal antibodies$xTherapeutic use$vPeriodicals
606   $aMonoclonal antibodies$vPeriodicals
606   $aMonoclonal antibodies$2fast$3(OCoLC)fst01025547
606   $aMonoclonal antibodies$xTherapeutic use$2fast$3(OCoLC)fst01025554
606   $aAntibodies, Monoclonal
608   $aPeriodical.
608   $aPeriodicals.$2fast
615  0$aMonoclonal antibodies$xTherapeutic use
615  0$aMonoclonal antibodies
615  7$aMonoclonal antibodies.
615  7$aMonoclonal antibodies$xTherapeutic use.
615 12$aAntibodies, Monoclonal.
676   $a615
712 02$aTaylor & Francis,
906   $aJOURNAL
912   $a9910144990003321
996   $aMAbs$92074386
997   $aUNINA